We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
+$2.34B
Cap. Flow
+$2.62B
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
8,008
New
182
Increased
3,096
Reduced
3,760
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 6.16%
2 Financials 5.29%
3 Healthcare 5.26%
4 Consumer Discretionary 4.52%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLRA
5801
DELISTED
Telaria, Inc.
TLRA
$70K ﹤0.01%
10,119
-56,889
-85% -$473K
CYCN icon
5802
Cyclerion Therapeutics
CYCN
$15.2M
$69K ﹤0.01%
288
-24
-8% -$5.18K
DK icon
5803
PUT
Delek US
DK
$3.98B
$69K ﹤0.01%
1,900
+1,800
+1,800% +$66.3K
OPCH icon
5804
Option Care Health
OPCH
$3.58B
$69K ﹤0.01%
5,364
-2,585
-33% -$31.8K
SHOE
5805
Shoe Station Group
SHOE
$424M
$69K ﹤0.01%
4,252
-45,864
-92% -$637K
CEQP
5806
CALL
DELISTED
Crestwood Equity Partners LP
CEQP
$69K ﹤0.01%
1,900
-500
-21% -$18.1K
FOCS
5807
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$69K ﹤0.01%
2,884
-5,605
-66% -$138K
VEDL
5808
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$69K ﹤0.01%
7,921
-7,508
-49% -$64.5K
ACWX icon
5809
iShares MSCI ACWI ex US ETF
ACWX
$11.2B
$68K ﹤0.01%
1,479
-252
-15% -$11.5K
AOD
5810
abrdn Total Dynamic Dividend Fund
AOD
$1.08B
$68K ﹤0.01%
8,135
-4,038
-33% -$33.3K
DIN icon
5811
PUT
Dine Brands
DIN
$462M
$68K ﹤0.01%
900
-1,500
-63% -$123K
FLXS icon
5812
Flexsteel Industries
FLXS
$307M
$68K ﹤0.01%
4,614
+2,656
+136% +$43.3K
GSHD icon
5813
Goosehead Insurance
GSHD
$2.51B
$68K ﹤0.01%
1,387
-100
-7% -$4.59K
LE icon
5814
CALL
Lands' End
LE
$378M
$68K ﹤0.01%
6,000
+1,500
+33% +$15.8K
MFC icon
5815
PUT
Manulife Financial
MFC
$73B
$68K ﹤0.01%
3,700
-2,400
-39% -$42.4K
OMAB icon
5816
Grupo Aeroportuario Centro Norte
OMAB
$5.14B
$68K ﹤0.01%
1,424
PNF
5817
DELISTED
PIMCO New York Municipal Income Fund
PNF
$68K ﹤0.01%
4,700
RSPF icon
5818
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$308M
$68K ﹤0.01%
1,550
-655
-30% -$28.3K
SBGI icon
5819
CALL
Sinclair Inc
SBGI
$1.02B
$68K ﹤0.01%
1,600
-11,200
-88% -$542K
UBX
5820
DELISTED
Unity Biotechnology
UBX
$68K ﹤0.01%
1,112
-390
-26% -$27.6K
VRN
5821
DELISTED
Veren
VRN
$68K ﹤0.01%
16,019
+5,243
+49% +$18.2K
ATRS
5822
DELISTED
Antares Pharma, Inc.
ATRS
$68K ﹤0.01%
20,342
-24,819
-55% -$81.7K
HUD
5823
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$68K ﹤0.01%
5,526
-4,666
-46% -$57.8K
AVAL icon
5824
Grupo Aval
AVAL
$5.82B
$67K ﹤0.01%
8,881
CFG icon
5825
PUT
Citizens Financial Group
CFG
$30.1B
$67K ﹤0.01%
1,900

Similar funds

Citigroup's Q3 2019 Portfolio in Review

As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
  • Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
  • Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
  • Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
  • Citigroup opened 182 new positions and closed 268 in Q3 2019.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.